Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Creative Biomolecules, Stryker extend OP-1 agreement

May 17, 1996

Estraderm MX launched in U.K.

May 10, 1996

Estring approved for marketing in U.S.

May 10, 1996

Muse safety and efficacy reported at urology meeting

May 10, 1996

Sildenafil demonstrates efficacy in erectile dysfunction Rx

May 10, 1996

AI-401 progresses to phase II

May 10, 1996

EU approval granted for Humalog

May 10, 1996

Sandoz synthesizes new antidiabetic agents

May 10, 1996

Yakult claims ACAT inhibitor from natural source

May 10, 1996

Hoechst claims bile acid sequestrants

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.